SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001851734-22-000518
Filing Date
2022-08-31
Accepted
2022-08-31 16:53:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A vtgn20220831_defa14a.htm DEFA14A 11067
2 notice01.jpg GRAPHIC 179413
3 notice02.jpg GRAPHIC 235496
  Complete submission text file 0001851734-22-000518.txt   580427
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-37761 | Film No.: 221218525
SIC: 2834 Pharmaceutical Preparations